Temporal Modulation of Acute Radiation Injury by Post-Exposure PARP-1 versus ATR Kinase Inhibition.<h4>Background</h4>PARP-1 and ATR inhibitors have been employed as radiosensitizers in cancer therapy. Here, PARP1 is linked to cancer.